Literature DB >> 30446225

Syk and JNK signaling pathways are involved in inflammasome activation in macrophages infected with Streptococcus pneumoniae.

Siwei Feng1, Qingyuan Huang1, Chao Ye1, Rui Wu1, Guihua Lei1, Jiali Jiang1, Tingting Chen1, Yuanyi Peng1, Rendong Fang2.   

Abstract

Streptococcus pneumoniae is a pathogen of significant clinical importance worldwide that can cause severe invasive diseases, such as pneumonia, otitis media and meningitis. Inflammsomes has been reported to participate in host defense against S. pneumoniae infection. S. pneumoniae could induce the assembly of the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3)/absent in melanoma 2 (AIM2) inflammasome, which mediates the activation of caspase-1 and the subsequent maturation of Interleukin-1β (IL-1β). However, the precise signals that activate inflammasomes during pneumococcal infection remain to be fully elucidated. In the present study, primary mouse macrophages were selected as a cell model, and the effects of kinases on inflammasome activity induced by S. pneumoniae infection were examined by ELISA and western blotting after pretreatment with a kinase inhibitor. Here, we show that Syk and JNK signaling are required for S. pneumoniae-induced activation of the inflammasome. Inhibitors of Syk and JNK almost abolished the oligomerization of apoptosis-associated speck-like protein containing a caspase-activating and recruitment domain (ASC) and subsequent caspase-1 activation and IL-1β secretion. Moreover, pneumolysin (PLY) participated in this process and was critical for Syk/JNK activation. These results suggested that the Syk/JNK signaling pathway may play a vital role in the inflammasome activation and modulate host immune responses against S. pneumoniae.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammasome; JNK; Pneumolysin; Streptococcus pneumoniae; Syk

Mesh:

Substances:

Year:  2018        PMID: 30446225     DOI: 10.1016/j.bbrc.2018.11.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Mst1/2-ALK promotes NLRP3 inflammasome activation and cell apoptosis during Listeria monocytogenes infection.

Authors:  Aijiao Gao; Huixin Tang; Qian Zhang; Ruiqing Liu; Lin Wang; Yashan Liu; Zhi Qi; Yanna Shen
Journal:  J Microbiol       Date:  2021-04-20       Impact factor: 3.422

Review 2.  Immune Responses in the Glaucomatous Retina: Regulation and Dynamics.

Authors:  Valery I Shestopalov; Markus Spurlock; Oliver W Gramlich; Markus H Kuehn
Journal:  Cells       Date:  2021-08-03       Impact factor: 6.600

3.  Cytolethal distending toxin-induced release of interleukin-1β by human macrophages is dependent upon activation of glycogen synthase kinase 3β, spleen tyrosine kinase (Syk) and the noncanonical inflammasome.

Authors:  Bruce J Shenker; Lisa M Walker; Zeyed Zekavat; David M Ojcius; Pei-Rong Huang; Kathleen Boesze-Battaglia
Journal:  Cell Microbiol       Date:  2020-03-04       Impact factor: 3.715

4.  Novel Virulence Role of Pneumococcal NanA in Host Inflammation and Cell Death Through the Activation of Inflammasome and the Caspase Pathway.

Authors:  Yu-Wen Tseng; Chun-Chi Chang; Yung-Chi Chang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-11       Impact factor: 5.293

5.  ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3.

Authors:  Yufeng Zhang; Sheng Zhang; Yi Wang; Zhiqiang Yang; Zhe Chen; Nengqiao Wen; Min Yang; Zan Huang; Yuanlong Xie; Lin Cai
Journal:  Oxid Med Cell Longev       Date:  2021-11-15       Impact factor: 6.543

Review 6.  Current Understanding of Host Genetics of Otitis Media.

Authors:  Ruishuang Geng; Qingzhu Wang; Eileen Chen; Qing Yin Zheng
Journal:  Front Genet       Date:  2020-02-07       Impact factor: 4.599

Review 7.  Interplays between inflammasomes and viruses, bacteria (pathogenic and probiotic), yeasts and parasites.

Authors:  Hanna Antushevich
Journal:  Immunol Lett       Date:  2020-09-22       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.